This research article explores a strategy using bacteria-derived molecular patterns on cancer cell membranes to reprogram tumor macrophages, offering a potential macrophage-based immunotherapy angle that readers can evaluate for translational promise.
Key Takeaways
- Although macrophages are a powerful cell-based platform for cancer immunotherapy
- We show that decorating cancer cell membranes with bacteria-derived pathogen-associated molecular patterns (PAMPs)
- Bacteria-derived PAMPs were formulated into membrane-decorating nanoparticles